1-1 of 1
Keywords: major adverse cardiac event
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Myotrophin is a more powerful predictor of major adverse cardiac events following acute coronary syndrome than N-terminal pro-B-type natriuretic peptide

Sohail Q. Khan, Dominic Kelly, Paulene Quinn, Joan E. Davies, Leong L. Ng
Journal: Clinical Science
Clin Sci (Lond) (2007) 112 (4): 251–256.
https://doi.org/10.1042/CS20060191
Published: 17 January 2007
... in patients with human systolic heart failure; however, its role as a predictor of MACE (major adverse cardiac events) in patients with ACS (acute coronary syndrome) is unclear. In the present study, we sought to investigate this and compared myotrophin with NTproBNP (N-terminal pro-B-type natriuretic peptide...
View article titled, Myotrophin is a more powerful predictor of <span class="search-highlight">major</span> <span class="search-highlight">adverse</span> <span class="search-highlight">cardiac</span> <span class="search-highlight">events</span> following acute coronary syndrome than N-terminal pro-B-type natriuretic peptide
Open the PDF for Myotrophin is a more powerful predictor of <span class="search-highlight">major</span> <span class="search-highlight">adverse</span> <span class="search-highlight">cardiac</span> <span class="search-highlight">events</span> following acute coronary syndrome than N-terminal pro-B-type natriuretic peptide in another window